Role of hospital and patient factors in the outcome of reoperations for primary hyperparathyroidism: a retrospective multicenter cohort study

Author:

Nomine-Criqui Claire1,Nguyen-Thi Phi-Linh2,Van Slycke Sam3,Makay Ozer4,Brunaud Laurent1,Bergenfelz Anders5

Affiliation:

1. Department of Gastrointestinal and Metabolic Surgery (CVMC), University of Lorraine, CHRU Nancy – Hospital Brabois Adultes, and Faculty of Medicine, INSERM NGERE, «Nutrition, Genetics, Environmental Risks», Vandoeuvre-les-Nancy

2. Department of Medical Informatics and Evaluation, University of Lorraine, CHU Nancy, Nancy, France

3. Department of General and Endocrine Surgery, Onze-Lieve-Vrouw Hospital Aalst, Aalst, Belgium

4. Department of Surgery, Ege University Hospital, Izmir, Turkey

5. Department of Clinical Sciences, Lund University, and Department of Surgery and Gastroenterology, Skane University Hospital, Lund, Sweden

Abstract

Background: There are few data on outcomes after reintervention for persistent or recurrent primary hyperparathyroidism (PHPT). The authors hypothesized that the variation in outcomes at the hospital level after reoperation would be significant. After accounting for this variability, some patient-level clinical criteria could be identified to help inform treatment decisions in this patient population. The aim of this study was to determine whether there is significant variation in outcomes after reoperation for PHPT between hospitals (hospital-level analysis) and identify clinical factors (patient-level analysis) that influence postoperative outcomes. Materials and methods: This retrospective multicenter cohort study was performed using the Eurocrine registry. Data from 11 countries and 76 hospitals from January 2015 to October 2020 were extracted. A generalized linear mixed model was used to assess the variation in outcomes at the hospital level and to identify risk factors of postoperative outcomes at the patient level. The primary endpoint (textbook outcome) was achieved when all six of the following postoperative conditions were met: no hypocalcemia or persistent hypercalcemia, no laryngeal nerve injury, no negative exploration, no normal parathyroid gland only on histopathology, and no postoperative death. Results: Among 13 593 patients who underwent parathyroidectomy for PHPT, 617 (4.5%) underwent reoperative parathyroidectomy. At follow-up, 231 patients (37.4%) were hypocalcemic, 346 (56.1%) were normocalcemic without treatment, and 40 (6.5%) had persistent hypercalcemia. Textbook outcomes were achieved in 321 (52.0%) patients. The hospital-level variation in textbook outcome rates was significant (P<0.001), and this variation could explain 29.1% of the observed outcomes. The criterion that remained significant after controlling for inter-hospital variation was ‘a single lesion on sestamibi scan or positron emission tomography (PET) imaging’ (odds ratio 2.08, 95% confidence interval 1.24–3.48; P=0.005). Conclusion: Outcomes after reoperation are significantly associated with hospital-related factors. A ‘single lesion observed on preoperative sestamibi scan or PET’ appears relevant to select patients before reoperation.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3